GlassScriptPhysician profile
Juan C Sanchez
NPI 1003891656
$1,259.36
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $108 · 2021: $34.75 · 2023: $346 · 2024: $22.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $634.51 | 2019-2023 | Nuplazid |
| Acorda Therapeutics, INC | $143.75 | 2019-2020 | |
| Abbvie INC. | $102.62 | 2023 | Ubrelvy, Qulipta |
| Mdd US Operations, LLC | $56.32 | 2019-2020 | |
| Gilead Sciences, INC. | $47.14 | 2019 | |
| Alexion Pharmaceuticals, INC. | $39.08 | 2019 | |
| Lilly USA, LLC | $37.72 | 2019-2024 | Amyvid |
| Ucb, INC. | $36.54 | 2019 | |
| Allergan, INC. | $34.67 | 2019-2020 | |
| Tanabe Pharma America, INC. | $23.20 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $22.94 | 2019 | |
| Eisai INC. | $21.35 | 2021 | |
| Kyowa Kirin, INC. | $17.27 | 2020 | |
| Emd Serono, INC. | $17.02 | 2020 | |
| Biogen, INC. | $13.40 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $11.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.